Literature DB >> 7096578

Measuring patient compliance in antihypertensive therapy--some methodological aspects.

H Enlund.   

Abstract

The usefulness of prescription refilling patterns in assessing compliance was studied retrospectively in 331 subjects receiving antihypertensive drugs during 1 and 2 year follow-up periods in 1976 and 1977. The compliance distribution was J-shaped for both periods. The number of compliant patients decreased slightly when the follow-up period increased from 1 to 2 years. An arbitrary cutoff point (0.7) yielded 34% noncompliers during the 2 year period. By interviewing patients, an additional 5% of noncompliers so-called early drop-outs, were identified among those who had filled no antihypertensive prescriptions during the 2 year period. The second follow-up year yielded little additional information. Reliability of the results obtained with prescription monitoring was also assessed by interviewing patients concerning eventual hospital stays and physicians' verbal orders that were not recorded on the prescriptions. These factors did not affect the overall compliance distribution, even though some patients might have been classified incorrectly because of them. In research settings and in daily practice prescription monitoring is a useful tool for assessing patient compliance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096578     DOI: 10.1111/j.1365-2710.1982.tb00907.x

Source DB:  PubMed          Journal:  J Clin Hosp Pharm        ISSN: 0143-3180


  6 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

Review 2.  The implications of noncompliance with antihypertensive medication.

Authors:  B Girvin; G D Johnston
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

3.  Methylphenidate: use in daily practice.

Authors:  Jacqueline G Hugtenburg; Judith E Griekspoor; Ingrid De Boer; Eibert R Heerdink; Yung Hwo Tso; Antoine C G Egberts
Journal:  Pharm World Sci       Date:  2005-06

4.  Persistence with osteoporosis medication among newly-treated osteoporotic patients.

Authors:  Job F M van Boven; Pieter T de Boer; Maarten J Postma; Stefan Vegter
Journal:  J Bone Miner Metab       Date:  2013-04-11       Impact factor: 2.626

5.  Medication adherence: a review of pharmacy education, research, practice and policy in Finland.

Authors:  J Simon Bell; Hannes Enlund; Kirsti Vainio
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

6.  Safety and efficacy of fimasartan in patients with arterial hypertension (Safe-KanArb study): an open-label observational study.

Authors:  Jeong Bae Park; Ki-Chul Sung; Seok-Min Kang; Eun Joo Cho
Journal:  Am J Cardiovasc Drugs       Date:  2013-02       Impact factor: 3.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.